These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34975297)

  • 1. Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway.
    Wei PL; Lin JC; Hung CS; Makondi PT; Batzorig U; Chang TC; Huang CY; Chang YJ
    Int J Med Sci; 2022; 19(1):34-46. PubMed ID: 34975297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
    Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
    World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 4. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
    Liu YC; Tsai JJ; Weng YS; Hsu FT
    Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase 1: A target in the capacity of dimeric ECG and EGCG procyanidins to inhibit colorectal cancer cell invasion.
    Zhu W; Oteiza PI
    Redox Biol; 2023 Sep; 65():102827. PubMed ID: 37516013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bio-imaging of colorectal cancer models using near infrared labeled epidermal growth factor.
    Cohen G; Lecht S; Arien-Zakay H; Ettinger K; Amsalem O; Oron-Herman M; Yavin E; Prus D; Benita S; Nissan A; Lazarovici P
    PLoS One; 2012; 7(11):e48803. PubMed ID: 23144978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
    Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
    Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.
    Gbenedio OM; Bonnans C; Grun D; Wang CY; Hatch AJ; Mahoney MR; Barras D; Matli M; Miao Y; Garcia KC; Tejpar S; Delorenzi M; Venook AP; Nixon AB; Warren RS; Roose JP; Depeille P
    JCI Insight; 2019 Jun; 5(15):. PubMed ID: 31237864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.
    Bae JA; Yoon S; Park SY; Lee JH; Hwang JE; Kim H; Seo YW; Cha YJ; Hong SP; Kim H; Chung IJ; Kim KK
    Clin Cancer Res; 2014 Aug; 20(15):4115-28. PubMed ID: 24893630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rd Inhibits the Metastasis of Colorectal Cancer via Epidermal Growth Factor Receptor Signaling Axis.
    Phi LTH; Sari IN; Wijaya YT; Kim KS; Park K; Cho AE; Kwon HY
    IUBMB Life; 2019 May; 71(5):601-610. PubMed ID: 30576064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
    Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
    Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    J Exp Clin Cancer Res; 2018 Mar; 37(1):41. PubMed ID: 29499765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control.
    Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM
    J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling.
    Fan X; Liu M; Tang H; Leng D; Hu S; Lu R; Wan W; Yuan S
    J Surg Res; 2019 Aug; 240():48-59. PubMed ID: 30909065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.